These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 6930495)

  • 41. Field-dependence as a predictor of improvement in the treatment of heroin addicts.
    Arnon D; Kleinman MH; Kissin B
    Proc Natl Conf Methadone Treat; 1973; 2():1325-9. PubMed ID: 4808286
    [No Abstract]   [Full Text] [Related]  

  • 42. [Diagnosis and treatment of heroin addiction in the general hospital].
    Ravelli DP
    Ned Tijdschr Geneeskd; 1985 May; 129(21):977-9. PubMed ID: 4010805
    [No Abstract]   [Full Text] [Related]  

  • 43. The New York City Methadone Maintenance Treatment Program after two years - an overview.
    Newman RG; Kagen JG
    Proc Natl Conf Methadone Treat; 1973; 1():794-801. PubMed ID: 4808235
    [No Abstract]   [Full Text] [Related]  

  • 44. [Does maintenance treatment reduce the mortality rate of opioid addicts?].
    Scherbaum N; Specka M; Hauptmann G; Gastpar M
    Fortschr Neurol Psychiatr; 2002 Sep; 70(9):455-61. PubMed ID: 12215918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of level of anxiety, depression and hostility with methadone plasma concentration in opioid-dependent patients receiving methadone on a maintenance dosage schedule.
    Blake DA; Distasio C
    Proc Natl Conf Methadone Treat; 1973; 2():1308-16. PubMed ID: 4808284
    [No Abstract]   [Full Text] [Related]  

  • 46. [Factors associated with retention in a community-based methadone maintenance treatment among heroin addicts].
    Hao C; Wu JL; Ruan YH; Yao HM; Yang XG; Liu L; Qin GM; Chen KL; Yin L; Song BL; Wang N; Shao YM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jul; 41(4):250-3. PubMed ID: 17959041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Nursing care in ambulatory methadone programs. A comparative literature study between The Netherlands and The United States].
    Loth CA; van de Wijngaart GF
    Verpleegkunde; 1997 Aug; 12(3):150-9. PubMed ID: 9385233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadone.
    Woody GE; O'Brien CP; Rickels K
    Am J Psychiatry; 1975 Apr; 132(4):447-50. PubMed ID: 1091161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Heroin addicts in substitution programs].
    Baumann T; Battegay R; Rauchfleisch U
    Schweiz Med Wochenschr; 1993 May; 123(20):1020-6. PubMed ID: 8511533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased utilization of counseling related to dose reduction in methadone maintenance.
    Creel S; Berkson R; Reilly J; Bulter P; Walker B; Carrozza L; Morrison J; O'Connell R; Patch V
    Proc Natl Conf Methadone Treat; 1973; 2():957-62. PubMed ID: 4808326
    [No Abstract]   [Full Text] [Related]  

  • 51. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users.
    Shi J; Zhao LY; Copersino ML; Fang YX; Chen Y; Tian J; Deng Y; Shuai Y; Jin J; Lu L
    Eur J Pharmacol; 2008 Jan; 579(1-3):160-6. PubMed ID: 17977528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The paranoid schizophrenic in a methadone maintenance program.
    Salzman B; Kurian M; Demirjian A; Morant E; Dowell S; Miller I; Royo W
    Proc Natl Conf Methadone Treat; 1973; 2():1304-7. PubMed ID: 4808283
    [No Abstract]   [Full Text] [Related]  

  • 53. The spectrum and causes of liver diseases in narcotic addicts.
    Gelb AM; Mildvan D; Stenger RJ
    Am J Gastroenterol; 1977 Apr; 67(4):314-8. PubMed ID: 879147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function.
    Sacerdote P; Franchi S; Gerra G; Leccese V; Panerai AE; Somaini L
    Brain Behav Immun; 2008 May; 22(4):606-13. PubMed ID: 18294814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunological function in active heroin addicts and methadone-maintained former addicts: observations and possible mechanisms.
    Kreek MJ
    NIDA Res Monogr; 1990; 105():75-81. PubMed ID: 1876153
    [No Abstract]   [Full Text] [Related]  

  • 56. Criminality in heroin addicts before, during, and after methadone treatment.
    Alexander M; McCaslin C
    Am J Public Health; 1974 Dec; 64 Suppl 12(12 Suppl):51-6. PubMed ID: 4429176
    [No Abstract]   [Full Text] [Related]  

  • 57. Rheumatoid factor activity in heroin addicts on methadone maintenance.
    Spiera H; Oreskes I; Stimmel B
    Ann Rheum Dis; 1974 Mar; 33(2):153-6. PubMed ID: 4821389
    [No Abstract]   [Full Text] [Related]  

  • 58. Immune status of unselected methadone maintained former heroin addicts.
    Kreek MJ; Khuri E; Flomenberg N; Albeck H; Ochshorn M
    Prog Clin Biol Res; 1990; 328():445-8. PubMed ID: 2304962
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunologic dysfunction in heroin addicts.
    Brown SM; Stimmel B; Taub RN; Kochwa S; Rosenfield RE
    Arch Intern Med; 1974 Dec; 134(6):1001-6. PubMed ID: 4433182
    [No Abstract]   [Full Text] [Related]  

  • 60. Why is methadone maintenance successful?
    Bourne PG; Slade J
    Proc Natl Conf Methadone Treat; 1973; 2():1086-92. PubMed ID: 4808253
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.